ACE and achalasia-alacrima syndrome: For AAAs, metformin, ACE inhibitors, angiotensin II receptor antagonists, and thiazides are linked to slower growth, emphasizing the importance of cardiovascular risk management and the potential of metformin in reducing aneurysm growth [54].